Telix Prescription drugs Restricted (TLX) Presents at H.C. Wainwright twenty seventh Annual International


Telix Prescription drugs Restricted (NASDAQ:TLX) H.C. Wainwright twenty seventh Annual International Funding Convention September 9, 2025 12:00 PM EDT

Firm Individuals

Christian Behrenbruch – Co-Founder, MD, Group CEO & Government Director

Convention Name Individuals

Robert Burns – H.C. Wainwright & Co, LLC, Analysis Division

Presentation

Robert Burns
Managing Director & Senior Healthcare Analyst

Welcome to our subsequent fireplace chat. I am Robert Burns, Managing Director and Senior Biotech Analyst, H.C. Wainwright. And I’m joined as we speak by Christian Behrenbruch, the CEO of Telix Prescription drugs. Christian, thanks for becoming a member of us as we speak.

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Sure. Thanks for the chance.

Query-and-Reply Session

Robert Burns
H.C. Wainwright & Co, LLC, Analysis Division

So one of many issues that I first needed to start out off with was clearly, Telix has skilled fast development and transformation through the years. So are you able to share a few of the key components which have contributed to the success?

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Effectively, I feel the corporate is simply actually keen about radiopharmaceuticals. I feel one of many distinctive facets in regards to the firm is we do not actually consider in isotope platforms, proper? We expect that whenever you develop a radiopharmaceutical, you need to have a look at the scientific utility that you simply need to clear up.

It is best to take into consideration what pharmacophore achieves your organic goals finest. After which you need to select the appropriate isotope for the job. And so one of many issues that I feel is admittedly particular in regards to the firm, and it is mirrored within the infrastructure that we have constructed over the past — virtually — firm is sort of 10 years outdated, 8 years as a public firm is that agnosticism.

We would like a — we’re very — we’re a pure-play radio pharma firm. We consider that precision drugs is admittedly essential. That is form of one thing that is not



Source link

Related articles

SLB opens 21,000-bbl drilling fluids plant to assist Mozambique offshore operations

(WO) — SLB has commissioned a brand new liquid mud plant in Pemba, Mozambique, increasing its capability to arrange, retailer and ship drilling and completion fluids for offshore oil and fuel operations. The ability...

Which mini Xteink ereader must you purchase? I’ve crunched the numbers on all 4 fashions — here is my verdict as an X4 Professional...

The Xteink S4 could be the tiny ereader you’ve been ready for, as not like different Xteink units — and rival merchandise just like the Boox Picco — this runs Android.That comes with...

Micron Suffers Excessive AI Pessimism: Structural Demand Via 2031 (NASDAQ:MU)

This text was written byComply withI'm a full-time analyst involved in a variety of shares. With my distinctive insights and information, I hope to offer different traders with a contrasting view of my...

Why the CFTC Is Rewriting Swap Guidelines for Prediction Markets and How It Shifts the Stability of Energy

A $1.5 billion month-to-month market sits on the centre of Washington’s newest regulatory offensive, because the Commodity Futures Buying and selling Fee strikes to formally declare jurisdiction over the booming event-contract sector. On...

Credit score Unions Might Face 26 New Stablecoin Reporting Fields

Key TakeawaysCustody companies account for 17 of the 26 proposed reporting fields.NCUA targets the March 31, 2027, reporting date for implementation.The 47-hour burden estimate covers the total quarterly monetary report. Stablecoin Custody and...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com